A great highlight of our recent work by @YYexin et al in the @ScienceMagazine newsletter, written by @NerdyChristie, "Ghosts of viruses past could point to a way of combating all sorts of viruses" ๐ป
Link to our original paper here
https://t.co/sTr3CRucU3
Newsletter here
https://t.co/aukTHRm8F0
Excited to be visiting @VirusesImmunity at the 2nd @YaleCII symposium today to talk about #LongCovid - Where we are, where we need to go, and how we can get there.
REGISTRATION NOW AVAILABLE: Our fall symposium will take place on Friday, October 4th!
We are so excited to hear from 6 of our amazing faculty members and for the keynote delivered by @MichaelPelusoMD.
Virtual attendance is available! Register here: https://t.co/5q7LZNi4Z2
Congratulations to @DrMaureenHanson and her team on their groundbreaking study highlighting the impaired recovery and severe exertion intolerance in ME/CFS patients. This research marks a significant advancement in understanding the physiological dysfunctions associated with ME/CFS, providing valuable insights that could influence future treatment approaches. Your dedication and hard work are truly commendable. #MECFS
I'm inspired by my patients every single day and incredibly grateful to the NIH for empowering me to continue researching Long COVID.
"McAlpine Wins Grant to Investigate Causes of Post-COVID-19 Neurologic Condition" https://t.co/SCaisUI3B3 via @NeurologyYale
Congratulations to @hmkyale in leading @JACCJournals as new Editor-in-Chief ๐๐ฝ๐๐ฝ๐๐ฝ Just like he does in other settings, Harlan puts patients first.
"We are chasing impact, not impact factor. Our North Star will always be patients and the public, seeking benefits for them.."
We're very grateful to @PlzSolveCFS for visiting us at Yale, and honoring @VirusesImmunity with an award that recognizes her efforts to illuminate PAIS. It's exciting to think about the progress we can do TOGETHER to solve ME/CFS and related conditions!
https://t.co/LRTjkFPXpD
Incredible opportunity for scientists working on RNA-based therapies ๐ข @EKFStiftung is calling for nominations - candidates can be nominated by heads of research institutes or professional organizations. Nominations of younger and mid-career scientists are favored. #EFKPrize25
This important #LongCovid study was both independently replicated and extended by a report today by @VirusesImmunity@keylas3@PutrinoLab@SilvaJ_C and colleagues
https://t.co/eyzOsLocoq
Thread ๐
https://t.co/Zb4B4SQHVf
Sharing our new study by @keylas3, @SilvaJ_C, Rafael Bayarri Olmos et al (with T. Horvath & @PutrinoLab) showing that a passive transfer of IgG from patients with #longCOVID into mice recapitulates โฌ๏ธ pain and other symptoms ๐งต (1/)
https://t.co/J5I22Y4fnn
Join us in celebrating Dr. Akiko Iwasaki, a Women's Health Research at Yale Investigator, who was named to the #TIME100, @TIME's annual list of the world's most influential. Read Dr. Anthony Fauci's reflection on this momentous occasion: https://t.co/ciiaFELUcp @VirusesImmunity
TIME's list of the 100 Most Influential People in the world is out. I'm honored, delighted, and grateful to be a part of this incredible group #TIME100 ๐๐ผ๐๐ผ๐๐ผ @TIME
https://t.co/kL0vSNbcmz
Congratulations to AAI President Akiko Iwasaki for being named one of Time's most influential people of 2024! @VirusesImmunity@TIME@YaleCII https://t.co/aex6WEuF6r